Literature DB >> 19911283

Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.

Hannah L F Cooper1, Brian H Bossak, Barbara Tempalski, Samuel R Friedman, Don C Des Jarlais.   

Abstract

Pharmacies that sell over-the-counter (OTC) syringes are a major source of sterile syringes for injection drug users in cities and states where such sales are legal. In these cities and states, however, black injectors are markedly less likely to acquire syringes from pharmacies than white injectors. The present analysis documents spatial and temporal trends in OTC pharmacy access in New York City health districts over time (2001-2006) and investigates whether these trends are related to district racial/ethnic composition and to local need for OTC pharmacies. For each year of the study period, we used kernel density estimation methods to characterize spatial access to OTC pharmacies within each health district. Higher values on this measure indicate better access to these pharmacies. "Need" was operationalized using two different measures: the number of newly diagnosed injection-related AIDS cases per 10,000 residents (averaged across 1999-2001), and the number of drug-related hospital discharges per 10,000 residents (averaged across 1999-2001). District sociodemographic characteristics were assessed using 2000 US decennial census data. We used hierarchical linear models (HLM) for descriptive and inferential analyses and investigated whether the relationship between need and temporal trajectories in the Expanded Syringe Access Demonstration Program access varied by district racial/ethnic composition, controlling for district poverty rates. HLM analyses indicate that the mean spatial access to OTC pharmacies across New York City health districts was 12.71 in 2001 and increased linearly by 1.32 units annually thereafter. Temporal trajectories in spatial access to OTC pharmacies depended on both need and racial/ethnic composition. Within high-need districts, OTC pharmacy access was twice as high in 2001 and increased three times faster annually, in districts with higher proportions of non-Hispanic white residents than in districts with low proportions of these residents. In low-need districts, "whiter" districts had substantially greater baseline access to OTC pharmacies than districts with low proportions of non-Hispanic white residents. Access remained stable thereafter in low-need districts, regardless of racial/ethnic composition. Conclusions were consistent across both measures of "need" and persisted after controlling for local poverty rates. In both high- and low-need districts, spatial access to OTC pharmacies was greater in "Whiter" districts in 2001; in high-need districts, access also increased more rapidly over time in "whiter" districts. Ensuring equitable spatial access to OTC pharmacies may reduce injection-related HIV transmission overall and reduce racial/ethnic disparities in HIV incidence among injectors.

Entities:  

Mesh:

Year:  2009        PMID: 19911283      PMCID: PMC2791821          DOI: 10.1007/s11524-009-9399-7

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  52 in total

1.  Obstacles to needle exchange participation in Rhode Island.

Authors:  J D Rich; L Strong; C W Towe; M McKenzie
Journal:  J Acquir Immune Defic Syndr       Date:  1999-08-15       Impact factor: 3.731

2.  Geographic proximity, policy and utilization of syringe exchange programmes.

Authors:  R Rockwell; D C Des Jarlais; S R Friedman; T E Perlis; D Paone
Journal:  AIDS Care       Date:  1999-08

3.  Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses.

Authors:  S J Hutchinson; A Taylor; D J Goldberg; L Gruer
Journal:  Addiction       Date:  2000-06       Impact factor: 6.526

4.  On the wrong side of the tracts? Evaluating the accuracy of geocoding in public health research.

Authors:  N Krieger; P Waterman; K Lemieux; S Zierler; J W Hogan
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

5.  Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.

Authors:  N U Cotten-Oldenburg; P Carr; J M DeBoer; E K Collison; G Novotny
Journal:  J Acquir Immune Defic Syndr       Date:  2001-06-01       Impact factor: 3.731

6.  Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.

Authors:  S R Friedman; T Perlis; D C Des Jarlais
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

7.  Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users.

Authors:  Benny J Kottiri; Samuel R Friedman; Alan Neaigus; Richard Curtis; Don C Des Jarlais
Journal:  J Acquir Immune Defic Syndr       Date:  2002-05-01       Impact factor: 3.731

Review 8.  An integrated approach to measuring potential spatial access to health care services.

Authors:  A A Khan
Journal:  Socioecon Plann Sci       Date:  1992-10       Impact factor: 4.923

9.  Injection drug users report good access to pharmacy sale of syringes.

Authors:  Wendy Reich; Wilson M Compton; Joeseph C Horton; Linda B Cottler; Renee M Cunningham-Williams; Robert Booth; Merrill Singer; Carl Leukefeld; Joseph Fink; Tom J Stopka; Karen Fortuin Corsi; Michelle Staton Tindall
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

10.  "We don't carry that"--failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics.

Authors:  R S Morrison; S Wallenstein; D K Natale; R S Senzel; L L Huang
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

View more
  30 in total

1.  Retail redlining in New York City: racialized access to day-to-day retail resources.

Authors:  Naa Oyo A Kwate; Ji Meng Loh; Kellee White; Nelson Saldana
Journal:  J Urban Health       Date:  2013-08       Impact factor: 3.671

2.  Understanding the relationship between alcohol outlet density and life expectancy in Baltimore City: The role of community violence and community disadvantage.

Authors:  C Debra M Furr-Holden; Elizabeth D Nesoff; Victoria Nelson; Adam J Milam; Mieka Smart; Krim Lacey; Roland J Thorpe; Philip J Leaf
Journal:  J Community Psychol       Date:  2018-07-10

3.  Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City.

Authors:  Natalie D Crawford; Silvia Amesty; Alexis V Rivera; Katherine Harripersaud; Alezandria Turner; Crystal M Fuller
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308

4.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

5.  Pharmacists and harm reduction: A review of current practices and attitudes.

Authors:  Tyler Watson; Christine Hughes
Journal:  Can Pharm J (Ott)       Date:  2012-05

6.  Factors associated with presence of pharmacies and pharmacies that sell syringes over-the-counter in Los Angeles County.

Authors:  Thomas J Stopka; Estella M Geraghty; Rahman Azari; Ellen B Gold; Kathryn Deriemer
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

7.  Population-Attributable Risk Percentages for Racialized Risk Environments.

Authors:  Hannah L F Cooper; Kimberly Jacob Arriola; Regine Haardörfer; Colleen M McBride
Journal:  Am J Public Health       Date:  2016-08-23       Impact factor: 9.308

8.  Community-engaged development of a GIS-based healthfulness index to shape health equity solutions.

Authors:  Richard C Sadler; Christopher Hippensteel; Victoria Nelson; Ella Greene-Moton; C Debra Furr-Holden
Journal:  Soc Sci Med       Date:  2018-07-19       Impact factor: 4.634

9.  The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Authors:  Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

10.  Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA.

Authors:  Saira S Siddiqui; Richard F Armenta; Jennifer L Evans; Michelle Yu; Jazmine Cuevas-Mota; Kimberly Page; Peter Davidson; Richard S Garfein
Journal:  Int J Drug Policy       Date:  2015-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.